Pharmaceutical tablet
Latest Celgene Corporation Patents:
Description
The “APR” logo forming part of the claimed design is a registered trademark of Celgene Corporation.
The broken line showing of the number “10” in the figures is included for the purpose of illustrating environment and forms no part of the claimed design.
Claims
The ornamental design for a pharmaceutical tablet, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
3281620 | October 1966 | Miller |
4503031 | March 5, 1985 | Glassman |
D285364 | August 26, 1986 | Tovey |
D304626 | November 14, 1989 | Contractor et al. |
D334420 | March 30, 1993 | Gladfelter et al. |
D334421 | March 30, 1993 | Gladfelter et al. |
D377977 | February 11, 1997 | Price et al. |
D413972 | September 14, 1999 | Burrows |
D413973 | September 14, 1999 | Burrows |
D432641 | October 24, 2000 | Burrows |
D433750 | November 14, 2000 | Burrows |
D434846 | December 5, 2000 | Chen et al. |
D459798 | July 2, 2002 | Desesquelle et al. |
D506544 | June 21, 2005 | Rinker et al. |
D515202 | February 14, 2006 | Chen et al. |
D534646 | January 2, 2007 | Chang et al. |
D535016 | January 9, 2007 | Stawski et al. |
D549724 | August 28, 2007 | Niijima |
D549725 | August 28, 2007 | Niijima |
D564086 | March 11, 2008 | Nielsen et al. |
D636865 | April 26, 2011 | Vepuri |
D667430 | September 18, 2012 | Ouilhet et al. |
D671636 | November 27, 2012 | Nishino |
D685460 | July 2, 2013 | Illing et al. |
89374 | April 2000 | CA |
Patent History
Patent number: D735315
Type: Grant
Filed: Jun 25, 2012
Date of Patent: Jul 28, 2015
Assignee: Celgene Corporation (Summit, NJ)
Inventor: Srenivas S. Bhat (Kendall Park, NJ)
Primary Examiner: Ian Simmons
Assistant Examiner: Charles Hanson
Application Number: 29/425,538
Type: Grant
Filed: Jun 25, 2012
Date of Patent: Jul 28, 2015
Assignee: Celgene Corporation (Summit, NJ)
Inventor: Srenivas S. Bhat (Kendall Park, NJ)
Primary Examiner: Ian Simmons
Assistant Examiner: Charles Hanson
Application Number: 29/425,538
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101)